Phase 3 Psoriatic Arthritis Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 18 years old or older at the time of signing the consent form
• You have been diagnosed with Psoriatic Arthritis (PsA)
• You have had signs and symptoms of PsA for at least 3 months before the screening visit
• You meet a specific set of recognised medical standards used to confirm a PsA diagnosis (called CASPAR criteria — confirm with trial site)
• You currently have at least 3 painful joints and at least 3 swollen joints, confirmed at two separate visits
• You have at least one active skin patch of plaque psoriasis that is 2 cm or larger, OR you have nail or nail bed changes typical of psoriasis
• You have previously tried at least one of the following with not enough benefit: a standard anti-inflammatory painkiller (like ibuprofen or naproxen — note: this requirement does not apply if you are in the EU/EEA), OR a standard disease-modifying medication for arthritis, OR up to 2 biologic (advanced injectable or infused) arthritis medications

Who may not be able to join:

• You have another condition that could make it difficult to assess how well the study treatment is working, such as rheumatoid arthritis, lupus, Lyme disease, gout, fibromyalgia, or a related joint condition (confirm with trial site)
• You have a skin condition alongside your psoriasis that the study doctor believes would interfere with assessing your skin during the trial, such as certain other forms of psoriasis (for example, pustular, erythrodermic, guttate, inverse, or drug-triggered psoriasis)

Important: Always verify eligibility with the trial site directly before applying.